Product Name
|
Pazopanib
|
CAS
|
444731-52-6
|
MF
|
C21H23N7O2S
|
MW
|
437.52
|
Storage temp
|
Refrigerator
|
Appearance
|
white powder
|
Assay
|
99%min
|
Pazopanib
is an oral multi-targeted tyrosine kinase inhibitor that blocks multiple receptors including VEGFR1-3, PDGFR-α, PDGFR-β and c-KIT. Sorafenib and sunitinib are very similar.
Pazopanib Indications:
1. FDA-approved for patients with advanced kidney cancer.
2. FDA-approved for patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.
1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: